Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1967 1
1972 1
1973 1
1980 2
1982 1
1984 1
1994 1
1995 2
1998 1
2000 5
2001 4
2002 9
2003 2
2004 4
2005 4
2006 4
2007 6
2008 3
2009 7
2010 12
2011 10
2012 5
2013 10
2014 4
2015 5
2016 6
2017 8
2018 1
2019 4
2020 6
2021 4
2022 6
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Ghia P, Pluta A, Wach M, Lysak D, Kozak T, Simkovic M, Kaplan P, Kraychok I, Illes A, de la Serna J, Dolan S, Campbell P, Musuraca G, Jacob A, Avery E, Lee JH, Liang W, Patel P, Quah C, Jurczak W. Ghia P, et al. Among authors: kozak t. J Clin Oncol. 2020 Sep 1;38(25):2849-2861. doi: 10.1200/JCO.19.03355. Epub 2020 May 27. J Clin Oncol. 2020. PMID: 32459600 Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Circulating tumor DNA in Hodgkin lymphoma.
Maco M, Kupcova K, Herman V, Ondeckova I, Kozak T, Mocikova H, Havranek O; Czech Hodgkin Lymphoma Study Group. Maco M, et al. Among authors: kozak t. Ann Hematol. 2022 Nov;101(11):2393-2403. doi: 10.1007/s00277-022-04949-x. Epub 2022 Sep 8. Ann Hematol. 2022. PMID: 36074181 Free PMC article. Review.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R, Grigg A, Torkildsen Ø, Bo L, Lehmann AK, Havrdova EK, Krasulova E, Trnený M, Kozak T, van der Walt A, Butzkueven H, McCombe P, Skibina O, Lechner-Scott J, Willekens B, Cartechini E, Ozakbas S, Alroughani R, Kuhle J, Patti F, Duquette P, Lugaresi A, Khoury SJ, Slee M, Turkoglu R, Hodgkinson S, John N, Maimone D, Sa MJ, van Pesch V, Gerlach O, Laureys G, Van Hijfte L, Karabudak R, Spitaleri D, Csepany T, Gouider R, Castillo-Triviño T, Taylor B, Sharrack B, Snowden JA; MSBase Study Group Collaborators; MSBase Study Group Authors; Mrabet S, Garber J, Sanchez-Menoyo JL, Aguera-Morales E, Blanco Y, Al-Asmi A, Weinstock-Guttman B, Fragoso Y, de Gans K, Kermode A; MSBase Study Group. Kalincik T, et al. Among authors: kozak t. JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/jamaneurol.2023.1184. JAMA Neurol. 2023. PMID: 37437240 Free PMC article.
Rituximab-induced coagulopathy.
Novak J, Mocikova H, Pavlicek P, Gaherova L, Kozak T. Novak J, et al. Among authors: kozak t. Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16. Leuk Lymphoma. 2012. PMID: 22480246 Review. No abstract available.
Hematopoietic stem cell transplantation for multiple sclerosis.
Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T, Muraro PA, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW, Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R. Burt RK, et al. Among authors: kozak t. Arch Neurol. 2005 Jun;62(6):860-4. doi: 10.1001/archneur.62.6.860. Arch Neurol. 2005. PMID: 15956156 Review. No abstract available.
Clinical case: idelalisib-induced immunoglobulin flare.
Novak J, Havrda M, Gaherova L, Spicka J, Kozak T. Novak J, et al. Among authors: kozak t. Immunopharmacol Immunotoxicol. 2017 Aug;39(4):251-252. doi: 10.1080/08923973.2017.1318912. Epub 2017 May 19. Immunopharmacol Immunotoxicol. 2017. PMID: 28523957
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
Kalincik T, Sharmin S, Roos I, Massey J, Sutton I, Withers B, Freedman MS, Atkins H, Krasulova E, Kubala Havrdova E, Trneny M, Kozak T, Burman J, Macdonell R, Torkildsen Ø, Bø L, Lehmann AK, Sharrack B, Snowden J. Kalincik T, et al. Among authors: kozak t. J Neurol Neurosurg Psychiatry. 2024 Mar 27:jnnp-2023-332790. doi: 10.1136/jnnp-2023-332790. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38538060
137 results